ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue124,90117,33161120
Cost of Revenue162,249103,69076,36960,602
Gross Profit-37,348-86,359-76,308-60,482
Operating Expenses
Research Development149,189149,189149,189149,189
Selling General and Administrative255,062186,45678,70432,748
Non Recurring----
Others----
Total Operating Expenses417,311290,146155,07393,350
Operating Income or Loss-292,410-272,815-155,012-93,230
Income from Continuing Operations
Total Other Income/Expenses Net4,1262,763-9,101755
Earnings Before Interest and Taxes-292,410-272,815-155,012-93,230
Interest Expense----
Income Before Tax-288,284-270,052-164,113-92,475
Income Tax Expense1,1191,341330-
Minority Interest----
Net Income From Continuing Ops-289,403-271,393-164,443-92,475
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-289,403-271,393-164,443-92,475
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-289,403-271,393-164,443-92,475